$XXII another red day. Can’t blame markets Up only 12% since FDA approval Down 20% since that pop Down 40% since 3rd leg reveal Down 60% since high last year Still no PR Still no Revenue figures Still nothing on NZ Still nothing on Intl VLN Still nothing on MJ/Hemp revenues But we do have 1, count em - 1 market in the pipeline.. and we will “compensate” clerks to put this on the shelves. It won’t be Walgreen. It won’t be Chicago What a blown opportunity so far. What the F was management doing for months while waiting for VLN??
5
5
5 Likes